Skip to content
Home/Companies/Biotech/Vantage Biosciences
VB

Vantage Biosciences

Biotech·UK·Active·3yr hold

Vantage Biosciences is a biotech company, headquartered in UK.

Entry
2023
Hold
3yr
Status
Active
Est. EV
–

Who owns Vantage Biosciences?

Vantage Biosciences is currently owned by ALSA Ventures through ALSA Ventures European Biotechnology Fund (2020 vintage), since 2023.

Hand-verified · updated 2026-05-22

ALSA Ventures
Investor
ALSA Ventures
ALSA Ventures European Biotechnology Fund · 2020 · Life Sciences VC

Key facts

HQUK
SectorBiotech
StatusActive

More from ALSA Ventures European Biotechnology Fund

Other portfolio companies in the same fund.

ReproNovo
Active
BiotechSwitzerland· 2025
Axovia Therapeutics
Active
BiotechUK· 2023
Promatix
Active
BiotechUK· 2021
Montis Biosciences
Active
BiotechBelgium· 2020
Epsilogen
Active
BiotechUK· 2018

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings